• Home >
  • Vital Signs The Analyst's Perspective - July 2016 Issue

Vital Signs The Analyst's Perspective - July 2016 Issue

30-Aug-2016  /  Research Code: 9A35-00-4E-00-00  /  SKU: HC02674-GL-MR_18873  /  
Region: Global

USD 600.00

* Required Fields

USD 600.00

PAY BY INVOICE

Be the first to review this product

This Vital Signs issue discusses the clinical diagnostics laboratory tests payment system, approval of a Zika test kit, the impact on innovation of mergers in the pharma/biotech industry, and national healthcare expenditure projections through 2025.

Table of Contents

Vital Signs The Analyst's Perspective - July 2016 IssueVital Signs - July 2016 IssueJuly 2016 Issue




Keyword1

Keyword2

Keyword3

Related Research

Why Now is The Time for Interoperable Healthcare Solutions?

Release Date : 05-Jul-18

Region : Global

Novel Therapies for Rare and Genetic Diseases

Release Date : 29-Jun-18

Region : Global

Innovations in Pain Management: A Technology Blueprint to Counter Opiod Addiction

Release Date : 29-Jun-18

Region : Global

Organ-on-a-chip Innovations Fueling Drug Screening Applications

Release Date : 29-Jun-18

Region : Global

Innovations in Diabetes Cure, Safer CAR-T Therapy, and Pediatric Genetic Disease Treatment

Release Date : 29-Jun-18

Region : Global

Why Frost & Sullivan

Vision & Strategy

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Brand & Demand

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Technology & IP

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

Global Prespective

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.